LEADER 00000cam a2200733Ia 4500
001 ocn851417416
003 OCoLC
005 20160805111341.4
006 m o d
007 cr cnu---unuuu
008 130701s2013 nyua obf 001 0 eng d
019 851972264|a852252398
020 1617051675|q(electronic book)
020 9781617051678|q(electronic book)
020 |z9781620700051
020 |z1620700050
035 (OCoLC)851417416|z(OCoLC)851972264|z(OCoLC)852252398
040 YDXCP|beng|epn|cYDXCP|dN$T|dOCLCA|dE7B|dIDEBK|dCDX|dOCLCF
|dOCLCO|dOCLCQ|dGO3|dOCL|dOCLCQ|dOS2|dEBLCP|dVLB|dOCLCQ
049 RIDW
050 4 RC280.G5|bB46 2013eb
072 7 HEA|x039030|2bisacsh
072 7 MED|x062000|2bisacsh
082 04 616.99/465|223
090 RC280.G5|bB46 2013eb
100 1 Benoit, Michelle F.|0https://id.loc.gov/authorities/names/
n2013180837
245 10 Gynecologic oncology handbook :|ban evidence-based
clinical guide /|cMichelle F. Benoit, M. Yvette Williams-
Brown, Creighton L. Edwards.
264 1 New York :|bDemos Medical Publishing, LLC,|c[2013]
264 4 |c©2013
300 1 online resource (viii, 355 pages) :|billustrations
336 text|btxt|2rdacontent
337 computer|bc|2rdamedia
338 online resource|bcr|2rdacarrier
340 |gpolychrome|2rdacc
347 text file|2rdaft
504 Includes bibliographical references and index.
505 0 Cover; Title; Copyright; Contents; Preface; Chapter 1:
Gynecologic Oncology Referral Parameters; I. Endometrial
Cancer; II. Pelvic Mass; III. Cervical Cancer; IV. Vaginal
Cancer; V. Vulvar Cancer; VI. Gestational Trophoblastic
Disease; Chapter 2: Disease Sites; A: Preinvasive Disease;
I. Cervical Intraepithelial Neoplasia (CIN); II. Vulvar
Intraepithelial Neoplasia; III. Vaginal Intraepithelial
Neoplasia (VAIN); IV. Dysplasia and HIV; References; B:
Cervical Cancer; I. Characteristics; II. Pretreatment
Workup; III. Histology; IV. Staging; V. Overall survival
by stage; VI. Treatment.
505 8 VII. Surgical TreatmentVIII. Radiotherapy; IX. Adjuvant
Posthysterectomy Treatment; X. Advanced Disease; XI.
Recurrent Disease; XII. Survival; XIII. Prognostic Factors
for Survival; XIV. Follow-Up; XV. Notable Trials in
Cervical Cancer; References; C: Ovarian Cancer; I. General
Characteristics; II. General Workup; III. General
Treatment; IV. Histology; V. General Staging; Epithelial
Ovarian Cancer; I. Characteristics; II. Workup; III.
Histology; IV. Staging; V. Treatment; VI. Chemotherapy for
Epithelial Ovarian Cancer; VII. Treatment by Stage; VIII.
Second-look laparotomy; IX. Recurrence.
505 8 X. Secondary cytoreductionXI. Cerebellar degeneration;
XII. Survival; XIII. Survival Care; XIV. Epithelial
Ovarian Cancer Trials; Ovarian Tumors of Low Malignant
Potential (LMP); I. Characteristics; II. Histology; III.
Workup; IV. Staging; V. Treatment; VI. Recurrence; VII.
Survival; VIII. Survival Care; Fallopian Tube Cancer; I.
Characteristics; II. Workup; III. Histology; IV. Staging;
V. Treatment; VI. Survival; VII. Survival care; Primary
Peritoneal Cancer; Germ Cell Tumors (GCT); I.
Characteristics; II. Workup; III. Staging; IV. Treatment;
V. Recurrence; VI. Follow-Up.
505 8 VII. Histological Subtypes and Directed TherapiesVIII.
Germ Cell Tumor Trials; IX. Chemotherapy Protocols for
Ovarian GCT; Sex Cord Stromal Tumors; I. Characteristics;
II. Workup; III. Staging; IV. Treatment; V. Histology; VI.
5 Y Survival; VII. Sex Cord Stromal Tumor Trials;
References; D: Uterine Cancer; I. Characteristics; II.
Prognostic factors; III. Pretreatment Workup; IV.
Histology; V. Staging; VI. Grade is specified as a 3-
tiered system; VII. Treatment; VIII. Recurrence; IX.
Postoperative hormonal replacement therapy; X. Synchronous
ovarian neoplasm; XI. Survival; XII. Follow-Up.
505 8 XIII. TamoxifenNotable Studies in Uterine Cancer; I. High-
Risk Early-Stage Disease Adjuvant Therapy Studies; Uterine
Sarcomas; I. Characteristics; V. Prognostic factors; VI.
Follow-Up; References; E: Vulvar Cancer; I.
Characteristics; II. Workup; III. Histology; IV. Staging;
V. Treatment; VI. Recurrence; VII. Survival; VIII. Follow-
up; Notable Studies; References; F: Vaginal Cancer; I.
Characteristics; II. Pretreatment Workup; III. Histology;
IV. Staging; V. Treatment; VI. Recurrent Disease; VII.
Survival; VIII. Follow-up; G: Gestational Trophoblastic
Disease; I. Characteristics.
520 Gynecologic Oncology Rotation Quick Reference provides a
comprehensive yet concise, practical guide for fellows,
residents, and specialist trainees in the diagnosis and
management of gynecologic cancers. The book addresses the
fundamentals of gynecologic oncology, including staging,
surgical technique, comorbidity diagnosis and management,
adjuvant therapies including chemotherapy and radiation,
and survival and palliative care. The focus is on specific
management decision-making and the book provides the basic
information needed to guide the clinician on the ward or
in the clinic including cl.
588 0 Print version record.
590 eBooks on EBSCOhost|bEBSCO eBook Subscription Academic
Collection - North America
650 0 Generative organs, Female|xCancer|vHandbooks, manuals,
etc.|0https://id.loc.gov/authorities/subjects/sh2010009264
650 7 Generative organs, Female|xCancer.|2fast|0https://
id.worldcat.org/fast/939917
650 12 Genital Neoplasms, Female|xtherapy.|0https://
id.nlm.nih.gov/mesh/D005833Q000628
650 22 Genital Neoplasms, Female|xdiagnosis.|0https://
id.nlm.nih.gov/mesh/D005833Q000175
650 22 Intraoperative Complications.|0https://id.nlm.nih.gov/mesh
/D007431
650 22 Postoperative Complications.|0https://id.nlm.nih.gov/mesh/
D011183
650 22 Pregnancy Complications, Neoplastic.|0https://
id.nlm.nih.gov/mesh/D011252
655 2 Handbook.|0https://id.nlm.nih.gov/mesh/D020479
655 4 Electronic books.
655 7 Handbooks and manuals.|2fast|0https://id.worldcat.org/fast
/1423877
655 7 Handbooks and manuals.|2lcgft|0https://id.loc.gov/
authorities/genreForms/gf2014026109
700 1 Williams-Brown, M. Yvette|q(Marian Yvette)|0https://
id.loc.gov/authorities/names/n2013180838
700 1 Edwards, Creighton L.|0https://id.loc.gov/authorities/
names/n2013180839
776 08 |iPrint version:|aBenoit, Michelle F., author.
|tGynecologic oncology handbook|z9781620700051|w(DLC)
2013004085
856 40 |uhttps://rider.idm.oclc.org/login?url=http://
search.ebscohost.com/login.aspx?direct=true&scope=site&
db=nlebk&AN=596362|zOnline eBook. Access restricted to
current Rider University students, faculty, and staff.
856 42 |3Instructions for reading/downloading this eBook|uhttp://
guides.rider.edu/ebooks/ebsco
901 MARCIVE 20231220
948 |d20161013|cEBSCO|tebscoebooksacademic new |lridw
994 92|bRID
